SFM
VRCA icon

Sphera Funds Management’s Verrica Pharmaceuticals VRCA Stock Holding History

Sphera Funds Management’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,700
Closed -$791K – 122
2018
Q4 		$791K Sell
9,700
-2,000
-17% -$243K 0.09% 91
2018
Q3 		$1.9M Sell
11,700
-880
-7% -$150K 0.22% 87
2018
Q2 		$2.48M Buy
+12,580
New +$2.46M 0.34% 76

Other funds holding VRCA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
CI
Conning Inc Hartford, Connecticut $3.34B AUM 25.19% 1-Year Est. Return

Sphera Funds Management's VRCA Position: Q1 2019 in Review

Sphera Funds Management sold out of Verrica Pharmaceuticals (VRCA) in Q1 2019, closing a stake of 9,700 shares — an estimated $791K sold.

Sphera Funds Management first reported a position in VRCA in Q2 2018 and held it in 3 quarters. The position peaked at $2.48M in Q2 2018. 40 funds tracked by Wall St. Rank hold VRCA as of Q1 2019.

  • Sphera Funds Management reported no remaining Verrica Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 9,700 Verrica Pharmaceuticals shares in Q1 2019, an estimated $791K.
  • Sphera Funds Management first reported a position in Verrica Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Sphera Funds Management's Verrica Pharmaceuticals position peaked at $2.48M in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.